5-fluorodihydrouracil has been researched along with Cancer of Gastrointestinal Tract in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aruldhas, BW; Chacko, RT; Jacob, J; Mathew, BS; Mathew, SK; Prabha, R; Singh, A | 1 |
| De Vries, EG; Groen, HJ; Maring, JG; Piersma, H; Uges, DR; van Dalen, A | 1 |
2 other study(ies) available for 5-fluorodihydrouracil and Cancer of Gastrointestinal Tract
| Article | Year |
|---|---|
Systemic exposure to 5-fluorouracil and its metabolite, 5,6-dihydrofluorouracil, and development of a limited sampling strategy for therapeutic drug management of 5-fluorouracil in patients with gastrointestinal malignancy.
Topics: Fluorouracil; Gastrointestinal Neoplasms; Humans; Pharmaceutical Preparations; Prospective Studies | 2021 |
Extensive hepatic replacement due to liver metastases has no effect on 5-fluorouracil pharmacokinetics.
Topics: Aged; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver; Liver Neoplasms; Male; Middle Aged | 2003 |